©The Author(s) 2026.
World J Gastroenterol. Feb 14, 2026; 32(6): 115556
Published online Feb 14, 2026. doi: 10.3748/wjg.v32.i6.115556
Published online Feb 14, 2026. doi: 10.3748/wjg.v32.i6.115556
Figure 3 Patterns of recurrence and metastasis after propensity score matching.
A: Hyperthermic intraperitoneal chemotherapy + adjuvant chemotherapy group; B: Adjuvant chemotherapy group. AC: Adjuvant chemotherapy; HIPEC: Hyperthermic intraperitoneal chemotherapy.
- Citation: Lian WL, Cai LS, Lian MQ, Lian MJ, Sun YQ, Lv CB, Huang GP, Huang RJ, Zhang YB, Zeng WM, Xu QH, Zhu QJ, Chen QX. Efficacy and safety of sequential hyperthermic intraperitoneal chemotherapy following surgery for pathological T staging 4 gastric cancer. World J Gastroenterol 2026; 32(6): 115556
- URL: https://www.wjgnet.com/1007-9327/full/v32/i6/115556.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i6.115556